StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
SPRB

Spruce Biosciences, Inc.

SPRB Nasdaq Pharmaceutical Preparations EDGAR ↗
$43.14
-0.23 -0.53%

Key statistics

from XBRL data in SEC filings
Market cap
$119M
Revenue (TTM)
$0.00
Net income (TTM)
-$37.2M
EPS (TTM)
$-35.82
P/E ratio
Dividend yield
Free cash flow
Cash
$54.1M
Total assets
$56.2M
Gross margin
52-week range
$7.00 – $240.00

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Director or officer change Jul 27, 2026 8-K Shareholder vote results May 26, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Results of operations (earnings release) May 13, 2026 8-K Entered a material agreement; Other events Apr 22, 2026 8-K Terminated a material agreement Mar 20, 2026 8-K Entered a material agreement; Terminated a material agreement; Results of operations (earnings release); Director or officer change Mar 9, 2026 10-K Fiscal year ended 2025-12-31 Mar 9, 2026 8-K Regulation FD disclosure; Other events Feb 5, 2026 8-K Entered a material agreement; Results of operations (earnings release); Took on a direct financial obligation; Unregistered sale of equity; Regulation FD disclosure Jan 8, 2026 8-K Director or officer change Dec 15, 2025 8-K Director or officer change Dec 12, 2025 10-Q Quarter ended 2025-09-30 Nov 10, 2025 8-K Results of operations (earnings release) Nov 10, 2025 8-K Director or officer change Oct 17, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Oct 8, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release) Aug 14, 2025 8-K Modified rights of security holders; Amended charter or bylaws; Shareholder vote results; Regulation FD disclosure Jul 24, 2025 8-K Delisting notice or listing-rule failure; Other events Jun 12, 2025 8-K Entered a material agreement; Unregistered sale of equity; Modified rights of security holders; Amended charter or bylaws; Item 5.08; Other events May 29, 2025 10-Q Quarter ended 2025-03-31 May 6, 2025 8-K Results of operations (earnings release) May 6, 2025 8-K Exit or disposal costs; Delisting notice or listing-rule failure Apr 25, 2025 10-K Fiscal year ended 2024-12-31 Apr 15, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Apr 15, 2025 8-K Results of operations (earnings release) Apr 1, 2025 8-K Director or officer change Dec 27, 2024 8-K Other events Dec 10, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 8-K Delisting notice or listing-rule failure Oct 28, 2024 10-Q Quarter ended 2024-06-30 Aug 12, 2024 8-K Results of operations (earnings release) Aug 12, 2024 8-K Entered a material agreement; Other events Jun 18, 2024 8-K Other events Jun 3, 2024 8-K Shareholder vote results May 24, 2024 10-Q Quarter ended 2024-03-31 May 13, 2024 8-K Results of operations (earnings release) May 13, 2024 8-K Delisting notice or listing-rule failure Apr 30, 2024